Julien Meissonnier
Chief Tech/Sci/R&D Officer at CATALENT, INC.
Profile
Founder of Accellix, Inc., Julien Meissonnier currently occupies the position of President & Director at Accellix, Inc. and Chief Scientific Officer & Vice President at Catalent, Inc., Chief Scientific Officer at Catalent Pharma Solutions, Inc. (a subsidiary of Catalent, Inc.). He previously occupied the position of President & Chief Executive Officer of Cardio Ventures Ltd., Manager-Business Development at Sol-Gel Technologies Ltd., Director-Marketing & Business Development at Evogene Ltd., Manager-Global Marketing at Novartis AG and Manager-Global Marketing at Ciba-Geigy AG (a subsidiary of Novartis AG) and Development Engineer at Rhone-Poulenc SA. He received a graduate degree from the University of Washington and an MBA from INSEAD.
Julien Meissonnier active positions
| Companies | Position | Start |
|---|---|---|
| CATALENT, INC. | Chief Tech/Sci/R&D Officer | 2019-11-18 |
Accellix, Inc.
 Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Founder | 2008-12-31 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Chief Tech/Sci/R&D Officer | 2019-09-30 |
Former positions of Julien Meissonnier
| Companies | Position | End |
|---|---|---|
Cardio Ventures Ltd.
 Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Chief Executive Officer | 2010-12-31 |
| SOL-GEL TECHNOLOGIES LTD. | Corporate Officer/Principal | - |
| NOVARTIS AG | Sales & Marketing | - |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Sales & Marketing | - |
| EVOGENE LTD. | Sales & Marketing | - |
Training of Julien Meissonnier
| University of Washington | Graduate Degree |
| INSEAD | Masters Business Admin |
| École Nationale Supérieure d'Ingénieurs de Caen | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NOVARTIS AG | Health Technology |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| EVOGENE LTD. | Health Technology |
| CATALENT, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Accellix, Inc.
Accellix, Inc. Medical SpecialtiesHealth Technology Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA. | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
| Rhone-Poulenc SA | Process Industries |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Cardio Ventures Ltd.
Cardio Ventures Ltd. Investment ManagersFinance Cardio Ventures Ltd is a venture capital firm. The firm headquartered in Jerusalem, Israel. | Finance |
- Stock Market
- Insiders
- Julien Meissonnier
